AN

Anand Nana Jagtap

Active Director Director DIN 09546578
DIN 09546578 First appointment Mar 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Anand Nana Jagtap

Data last updated:

Anand Nana Jagtap is a Director at Ementis Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Ementis Pharmaceuticals Private Limited reported revenue of ₹92,006 (FY 2023).

DIN 09546578
Primary Designation Director
Industry Chemicals
First Appointment 24 Mar 2022
Oldest Company Age 4 yrs
Largest company Ementis Pharmaceuticals Private Limited · ₹92,006 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Mar 20222022₹92,006 (FY 2023)Active

Board colleagues of Anand Nana Jagtap

Directorship timeline

Open interactive timeline →
Ementis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anand Nana Jagtap

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Nana Jagtap

Anand Nana Jagtap currently holds 1 directorship: Ementis Pharmaceuticals Private Limited (Director, since 24 Mar 2022, revenue ₹92,006 (FY 2023)).

Anand Nana Jagtap was first appointed on 24 Mar 2022 as Director at Ementis Pharmaceuticals Private Limited.

The current boards of Anand Nana Jagtap's companies include Meena Yogesh Nirmal (Ementis Pharmaceuticals Private Limited), Pradeep Kumar (Ementis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available